20 May 2013
Keywords: Arena Pharma, Temanogrel, Ildong Pharma, South Korea, Cardiovascular conditions
Article | 28 November 2012
The USA’s Arena Pharmaceuticals (Nasdaq: ARNA) has entered into a co-development and license agreement with South Korea’ ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
28 November 2012
© 2013 thepharmaletter.com